PT1171160E - Metodo e meios para tratar o sindroma pos poliomielite - Google Patents

Metodo e meios para tratar o sindroma pos poliomielite

Info

Publication number
PT1171160E
PT1171160E PT00925790T PT00925790T PT1171160E PT 1171160 E PT1171160 E PT 1171160E PT 00925790 T PT00925790 T PT 00925790T PT 00925790 T PT00925790 T PT 00925790T PT 1171160 E PT1171160 E PT 1171160E
Authority
PT
Portugal
Prior art keywords
treating
sindroma
poliomielite
pos
globulin
Prior art date
Application number
PT00925790T
Other languages
English (en)
Inventor
Gonzalez Henrik
Borg Kristian
Original Assignee
Xepol Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xepol Ab filed Critical Xepol Ab
Publication of PT1171160E publication Critical patent/PT1171160E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Color Electrophotography (AREA)
PT00925790T 1999-04-01 2000-03-30 Metodo e meios para tratar o sindroma pos poliomielite PT1171160E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/285,125 US6071516A (en) 1999-04-01 1999-04-01 Treatment of Post-Polio Syndrome with gamma-globulin

Publications (1)

Publication Number Publication Date
PT1171160E true PT1171160E (pt) 2005-09-30

Family

ID=23092831

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00925790T PT1171160E (pt) 1999-04-01 2000-03-30 Metodo e meios para tratar o sindroma pos poliomielite

Country Status (11)

Country Link
US (1) US6071516A (pt)
EP (1) EP1171160B1 (pt)
JP (1) JP4226789B2 (pt)
AT (1) ATE296640T1 (pt)
AU (1) AU772499B2 (pt)
CA (1) CA2368184C (pt)
DE (1) DE60020550T2 (pt)
ES (1) ES2243257T3 (pt)
NZ (1) NZ514490A (pt)
PT (1) PT1171160E (pt)
WO (1) WO2000059539A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008156418A1 (en) * 2007-06-19 2008-12-24 Astrazeneca Ab A method for screening or diagnosis of postpolio syndrome and fibromyalgia
CA3151943A1 (en) * 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration

Also Published As

Publication number Publication date
DE60020550T2 (de) 2006-04-27
ES2243257T3 (es) 2005-12-01
US6071516A (en) 2000-06-06
WO2000059539A1 (en) 2000-10-12
CA2368184C (en) 2012-05-08
DE60020550D1 (de) 2005-07-07
JP4226789B2 (ja) 2009-02-18
JP2002541121A (ja) 2002-12-03
NZ514490A (en) 2004-01-30
AU772499B2 (en) 2004-04-29
EP1171160B1 (en) 2005-06-01
ATE296640T1 (de) 2005-06-15
AU4442500A (en) 2000-10-23
EP1171160A1 (en) 2002-01-16
CA2368184A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
WO2002100390A3 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
NO20014842D0 (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
HK1068606A1 (en) Novel aminobenzoephenones
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR0213293A (pt) Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
SE9603725D0 (sv) New teatment
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
DE69935526D1 (de) Supramolekulare komplexe enthaltende arzneimittel
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
SE9902597D0 (sv) New use
PT1171160E (pt) Metodo e meios para tratar o sindroma pos poliomielite
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
PT980253E (pt) Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
SE0102887D0 (sv) New formulation
MX2022011188A (es) Derivado biciclico fusionado, metodo de preparacion y uso farmaceutico del mismo.
FR2839450B1 (fr) Preparation medicamenteuse notamment pour le traitement des hernies discales
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
BR9708037A (pt) Método para o tratamento de abuso de substância